ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $268 | -63.6% | 12,873 | -67.1% | 0.03% | -60.3% |
| Q1 2023 | $736 | -99.8% | 39,075 | +80.8% | 0.07% | +94.3% |
| Q3 2022 | $354,000 | -63.9% | 21,618 | -46.6% | 0.04% | -69.8% |
| Q1 2022 | $981,000 | +371.6% | 40,490 | +374.1% | 0.12% | +452.4% |
| Q2 2021 | $208,000 | -39.9% | 8,540 | +19.7% | 0.02% | -59.6% |
| Q2 2020 | $346,000 | +8.5% | 7,137 | -4.4% | 0.05% | +2.0% |
| Q4 2019 | $319,000 | -20.1% | 7,465 | -32.7% | 0.05% | -27.1% |
| Q3 2019 | $399,000 | +94.6% | 11,087 | +44.6% | 0.07% | +100.0% |
| Q2 2019 | $205,000 | -28.8% | 7,667 | -57.0% | 0.04% | -30.0% |
| Q4 2018 | $288,000 | – | 17,815 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |